René Kuijten

René Kuijten currently works at Stichting Steun Emma Kinderziekenhuis, as Chairman from 2012, Trinity Biosystems, Inc., as Director, Nederlandse Vereniging van Participatiemaatschappijen, as Director, Mckinsey Alumni Association, as Director, Max Geldens Stichting, as Director, Neuravi Ltd., as Director, Artios Pharma Ltd., as Director, Regiegroep Lsh, as Member, and EQT Life Sciences Group BV, as Partner & Head of EQT Life Sciences from 2022.
Dr. Kuijten also formerly worked at Aton SA, as Director, Ipsat Therapies Oy, as Director, Nexstim Oyj, as Director, Kreatech Biotechnology BV, as Director-Supervisory Board, DNage BV, as Director-Supervisory Board, Ipsen Bioinnovation Ltd., as Director, BMEYE BV, as Member-Supervisory Board in 2012, AstraZeneca AB, as Member-Supervisory Board, Kudos 2000 Ltd., as Member-Supervisory Board, Dr. Reddy's Research & Development BV, as Member-Supervisory Board from 2005 to 2010, Morphochem AG, as Member-Supervisory Board, Zealand Pharma A, as Member-Supervisory Board, European Federation of Pharmaceutical Industries & Assns, as Co-Leader, Kreatech Holding BV, as Member-Supervisory Board, McKinsey & Co., Inc. (Belgium), as Senior Manager, Mckinsey & Co., Inc. (Switzerland), as Senior Manager, and Mckinsey & Co., as Senior Manager.
Dr. Kuijten received his Masters Business Admin degree in 1994 from INSEAD, doctorate degree in 1992 from the University of Amsterdam, and graduate degree in 1991 and doctorate degree in 1991 from the University of Utrecht.